B2i Digital, Inc. will host the Life Sciences Virtual Investor Forum on Thursday, September 17, 2026, a fully online event produced by Virtual Investor Conferences. The forum will feature live 30-minute presentations and audience Q&A with seven companies, according to a press release issued by B2i Digital. Replays will be available on the B2i Digital and OTC Markets YouTube channels, and investors can register at https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/150412/september-17th-life-sciences-virtual-investor-forum?utm_source=b2i&utm_medium=marketing&utm_campaign=0917SeptLifeScienceVIC. Full event details and company profiles are available at https://b2idigital.com/sept-17-life-sciences-virtual-investor-forum.
The presenting companies and their scheduled times are: Sona Nanotech Inc. at 11:00 AM ET, Raphael Pharmaceutical at 11:30 AM ET, Amplia Therapeutics Ltd. at 2:00 PM ET, Adaptin Bio, Inc. at 2:30 PM ET, Acurx Pharmaceuticals, Inc. at 3:00 PM ET, CytoDyn Inc. at 3:30 PM ET, and 4DMedical Ltd. at 4:00 PM ET. All times are subject to change.
The lineup spans a photothermal cancer therapy built on gold nanorods, cannabinoid-based formulations in development for rheumatoid arthritis, chronic lung inflammation and autoimmune disease, and precision drug delivery technologies aimed at target tissues including behind the blood-brain barrier. The forum also features a new class of antibiotics in development for infections caused by bacteria listed as priority pathogens, a humanized monoclonal antibody being studied in solid-tumor oncology, a pipeline of Focal Adhesion Kinase inhibitors for cancer and fibrosis, and FDA-cleared four-dimensional respiratory imaging.
David Shapiro, Chief Executive Officer of B2i Digital, Inc., said, “Reading company filings is a great cure for insomnia, but if you want to stay awake and hear it directly from management, these conferences are the best way to get a real feel for the company. My favorite part is the Q&A and hearing how they handle the impromptu questions that are really on your mind.”
The forum matters because it gives investors direct access to executive management teams at a time when many companies in high-risk, high-reward life sciences sectors are seeking capital and visibility. Virtual Investor Conferences, an OTC Markets Group Inc. property, regularly features public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. B2i Digital serves as the Official Marketing Partner, leveraging its media network of more than 800 news, broadcast, and trade outlets and an audience of over 330 million monthly viewers to amplify the event.
For the industry, the forum highlights emerging therapies across oncology, fibrosis, antibiotics, and drug delivery—areas where innovation can address significant unmet medical needs. For investors, the live Q&A format offers a rare chance to probe management on strategy and science, potentially informing investment decisions. The event is free to attend online, and replays will be available for those unable to participate live. B2i Digital notes that it is not an affiliate of Virtual Investor Conferences and that the event content is for informational purposes only, not investment advice.
